Xoma Corp (GB:0M26)
UK Market

Xoma Stock Analysis & Ratings

GB:0M26 Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.00 - $0.00
Previous Close$17.52
Average Volume (3M)19.00
Market Cap$200.09M
P/E Ratio33.8
Next EarningsAug 09, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score2
EPS (TTM)0.52



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.



What was Xoma’s price range in the past 12 months?
Xoma lowest stock price was $0.00 and its highest was $0.00 in the past 12 months.
    What is Xoma’s market cap?
    Xoma’s market cap is $200.09M.
      What is Xoma’s price target?
      The average price target for Xoma is $69.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $69.00 ,the lowest forecast is $69.00. The average price target represents 293.84% Increase from the current price of $17.52.
        What do analysts say about Xoma?
        Xoma’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
          When is Xoma’s upcoming earnings report date?
          Xoma’s upcoming earnings report date is Aug 09, 2022 which is in 81 days.
            How were Xoma’s earnings last quarter?
            Xoma released its earnings results on May 05, 2022. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.363 by $0.043.
              Is Xoma overvalued?
              According to Wall Street analysts Xoma’s price is currently Undervalued.
                Does Xoma pay dividends?
                Xoma does not currently pay dividends.
                What is Xoma’s EPS estimate?
                Xoma’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Xoma have?
                Xoma has 11,420,000 shares outstanding.
                  What happened to Xoma’s price movement after its last earnings report?
                  Xoma reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.363. Following the earnings report the stock price went down -8.979%.
                    Which hedge fund is a major shareholder of Xoma?
                    Currently, no hedge funds are holding shares in GB:0M26


                    Xoma Stock Analysis

                    Smart Score
                    Price Target
                    ▲(293.84% Upside)
                    Moderate Buy
                    The Xoma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Xoma Corp

                    XOMA Corp. engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

                    Similar Stocks
                    Price & Change
                    Novo Nordisk
                    Eiger Biopharmaceuticals
                    Emergent Biosolutions

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis